Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724345 | SCV000224689 | uncertain significance | not provided | 2014-11-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724345 | SCV000617180 | uncertain significance | not provided | 2019-05-30 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Genome- |
RCV001275275 | SCV002055423 | uncertain significance | Agenesis of the corpus callosum with peripheral neuropathy | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000724345 | SCV002394215 | likely benign | not provided | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001275275 | SCV001460254 | uncertain significance | Agenesis of the corpus callosum with peripheral neuropathy | 2020-09-16 | no assertion criteria provided | clinical testing |